Bempedoic Acid: for Whom and When.

Journal Information

Full Title: Curr Atheroscler Rep

Abbreviation: Curr Atheroscler Rep

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of InterestA.C. has received honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Novartis, Recordati, Servier, and Sanofi and a grant from Daiichi Sankyo. M.R. received a grant from Daiichi Sankyo; M.B. speakers bureau: Amgen, Esperion, Herbapol, Kogen, KRKA, Novartis, Polpharma, Sanofi, Servier, Teva, Viatris, and Zentiva; consultant to Akcea, Amgen, Daichii Sankyo, Esperion, Freia Pharmaceuticals, Polfarmex, and Sanofi; and grants from Amgen, Viatris, Sanofi, and Valeant. S.C. has received payment or honoraria from Fidia, Techdow, and Bruno. C.R.S. has nothing to disclose. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest A.C. has received honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Novartis, Recordati, Servier, and Sanofi and a grant from Daiichi Sankyo. M.R. received a grant from Daiichi Sankyo; M.B. speakers bureau: Amgen, Esperion, Herbapol, Kogen, KRKA, Novartis, Polpharma, Sanofi, Servier, Teva, Viatris, and Zentiva; consultant to Akcea, Amgen, Daichii Sankyo, Esperion, Freia Pharmaceuticals, Polfarmex, and Sanofi; and grants from Amgen, Viatris, Sanofi, and Valeant. S.C. has received payment or honoraria from Fidia, Techdow, and Bruno. C.R.S. has nothing to disclose."

Evidence found in paper:

"Funding Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement. MR received research funding by Banca di Credito Cooperativo di Milano (2022)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025